FR2340735B1 - - Google Patents

Info

Publication number
FR2340735B1
FR2340735B1 FR7603754A FR7603754A FR2340735B1 FR 2340735 B1 FR2340735 B1 FR 2340735B1 FR 7603754 A FR7603754 A FR 7603754A FR 7603754 A FR7603754 A FR 7603754A FR 2340735 B1 FR2340735 B1 FR 2340735B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7603754A
Other languages
French (fr)
Other versions
FR2340735A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7603754A priority Critical patent/FR2340735A1/fr
Priority to SE7700804A priority patent/SE441528B/xx
Priority to US05/766,487 priority patent/US4107310A/en
Priority to DE19772705446 priority patent/DE2705446A1/de
Priority to DD7700197299A priority patent/DD129552A5/xx
Priority to CA271,429A priority patent/CA1089464A/fr
Priority to IL51413A priority patent/IL51413A/xx
Priority to GB5556/77A priority patent/GB1572482A/en
Priority to ES455804A priority patent/ES455804A1/es
Priority to ZA00770787A priority patent/ZA77787B/xx
Priority to BE174832A priority patent/BE851306A/xx
Priority to SU772450451A priority patent/SU867299A3/ru
Priority to DK056077A priority patent/DK150512C/da
Priority to NL7701398A priority patent/NL7701398A/xx
Priority to IE289/77A priority patent/IE44879B1/en
Priority to LU76742A priority patent/LU76742A1/xx
Priority to JP1313977A priority patent/JPS52116479A/ja
Priority to AU22218/77A priority patent/AU508345B2/en
Priority to CH172177A priority patent/CH620437A5/fr
Publication of FR2340735A1 publication Critical patent/FR2340735A1/fr
Application granted granted Critical
Publication of FR2340735B1 publication Critical patent/FR2340735B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
FR7603754A 1976-02-11 1976-02-11 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament Granted FR2340735A1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR7603754A FR2340735A1 (fr) 1976-02-11 1976-02-11 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
SE7700804A SE441528B (sv) 1976-02-11 1977-01-26 Sett att framstella nya 3-kinolin-karboxylsyraderivat
US05/766,487 US4107310A (en) 1976-02-11 1977-02-07 Quinoline-3-carboxamides
DD7700197299A DD129552A5 (de) 1976-02-11 1977-02-09 Verfahren zur herstellung von derivaten der 3-chinolinkarbonsaeure
CA271,429A CA1089464A (fr) 1976-02-11 1977-02-09 Procede de preparation de nouveaux derives de l'acide 3-quinoleine carboxylique
DE19772705446 DE2705446A1 (de) 1976-02-11 1977-02-09 Neue derivate der 3-chinolincarbonsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
SU772450451A SU867299A3 (ru) 1976-02-11 1977-02-10 Способ получени производных 3-хинолинкарбоновой кислоты или их солей
ES455804A ES455804A1 (es) 1976-02-11 1977-02-10 Un procedimiento de preparacion de nuevos derivados del aci-do 3-quinolein- carboxilico.
ZA00770787A ZA77787B (en) 1976-02-11 1977-02-10 New derivatives of 3-quinoline carboxylic acid,process for preparing them and pharmaceutical compositions
BE174832A BE851306A (fr) 1976-02-11 1977-02-10 Nouveaux derives de l'acide 3-quinoleine carboxylique
IL51413A IL51413A (en) 1976-02-11 1977-02-10 Derivatives of 3-quinoline carboxylic acid, process for preparing them and pharmaceutical compositions
DK056077A DK150512C (da) 1976-02-11 1977-02-10 Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
NL7701398A NL7701398A (nl) 1976-02-11 1977-02-10 Werkwijze ter bereiding van nieuwe chinoline- carbonzuur-3 derivaten, werkwijze ter vervaar- diging van farmaceutische preparaten hiermede, alsmede de aldus gevormde preparaten.
IE289/77A IE44879B1 (en) 1976-02-11 1977-02-10 N-heterocyclyl-4-hydroxy-quinoline-3-carboxamides
LU76742A LU76742A1 (enExample) 1976-02-11 1977-02-10
JP1313977A JPS52116479A (en) 1976-02-11 1977-02-10 Novel derivative of 33quinolinecarboxylic acid and method for its preparation and phamaceutical composition thereof
GB5556/77A GB1572482A (en) 1976-02-11 1977-02-10 N-hetero-cyclyl-4-hydrocy-quinoline-3-carboxamides
CH172177A CH620437A5 (enExample) 1976-02-11 1977-02-11
AU22218/77A AU508345B2 (en) 1976-02-11 1977-02-11 Derivatives of 3-quinoline carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7603754A FR2340735A1 (fr) 1976-02-11 1976-02-11 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
FR2340735A1 FR2340735A1 (fr) 1977-09-09
FR2340735B1 true FR2340735B1 (enExample) 1978-11-03

Family

ID=9168994

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7603754A Granted FR2340735A1 (fr) 1976-02-11 1976-02-11 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Country Status (19)

Country Link
US (1) US4107310A (enExample)
JP (1) JPS52116479A (enExample)
AU (1) AU508345B2 (enExample)
BE (1) BE851306A (enExample)
CA (1) CA1089464A (enExample)
CH (1) CH620437A5 (enExample)
DD (1) DD129552A5 (enExample)
DE (1) DE2705446A1 (enExample)
DK (1) DK150512C (enExample)
ES (1) ES455804A1 (enExample)
FR (1) FR2340735A1 (enExample)
GB (1) GB1572482A (enExample)
IE (1) IE44879B1 (enExample)
IL (1) IL51413A (enExample)
LU (1) LU76742A1 (enExample)
NL (1) NL7701398A (enExample)
SE (1) SE441528B (enExample)
SU (1) SU867299A3 (enExample)
ZA (1) ZA77787B (enExample)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190659A (en) * 1973-08-27 1980-02-26 Sandoz, Inc. Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
US4281131A (en) 1977-06-20 1981-07-28 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4273930A (en) * 1977-06-20 1981-06-16 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acid esters
US4187309A (en) * 1977-06-20 1980-02-05 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4221797A (en) * 1978-08-14 1980-09-09 Sandoz, Inc. Dihydroquinoline-one derivatives
FR2443467A1 (fr) * 1978-12-08 1980-07-04 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2482596A1 (fr) * 1980-05-19 1981-11-20 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament
US4266050A (en) * 1980-07-02 1981-05-05 American Home Products Corporation 1,2-Dihydro-4-hydroxy-2-imino-N-substituted-3-quinolinecarboxamide derivatives
IE52670B1 (en) 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
FR2523130A1 (fr) * 1982-03-15 1983-09-16 Roussel Uclaf Nouveaux derives de la n-dihydrothiazolyl-3-quinoleine carboxamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
HU190796B (en) * 1981-06-12 1986-11-28 Roussel Uclaf,Fr Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
FR2507602A1 (fr) * 1981-06-12 1982-12-17 Roussel Uclaf Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2537139B2 (fr) * 1982-03-15 1985-09-20 Roussel Uclaf Nouveau derive de la n-dihydrothiazolyl 3-quinoleine carboxamide, procede de preparation, application a titre de medicament et compositions le renfermant
FR2551437B2 (fr) * 1982-06-03 1985-10-25 Roussel Uclaf Nouveaux derives de l'acide 4-oh 3-quinoleine carboxylique substitues en 2, nouveau procede de preparation, leur application comme medicament et les compositions les renfermant et produits necessaires a leur preparation
FR2530633A1 (fr) * 1982-06-03 1984-01-27 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
FR2532939A1 (fr) * 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
FR2537140B1 (fr) * 1982-12-07 1986-07-18 Roussel Uclaf Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
SE452170B (sv) * 1983-10-03 1987-11-16 Boliden Ab Forfarande for utvinning av metall ur koppar och/eller edelmetall innehallande material som innehaller antimon och vismut
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
US4602014A (en) * 1984-07-09 1986-07-22 Ciba-Geigy Corporation Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
JPH0358559A (ja) * 1989-07-26 1991-03-13 Sekisui Chem Co Ltd 電話システム
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
US5412104A (en) * 1990-09-07 1995-05-02 Schering Corporation Ester and alkoxy substituted benzopyrans
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
DE4138820A1 (de) * 1991-11-26 1993-05-27 Basf Ag Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
TWI328009B (en) * 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
US8314124B2 (en) * 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
SE0400235D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New composition containing quinoline compounds
WO2006002421A2 (en) * 2004-06-24 2006-01-05 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
RU2556984C2 (ru) * 2004-06-24 2015-07-20 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы транспортеров атф-связывающей кассеты
WO2006087830A1 (ja) * 2005-02-18 2006-08-24 Kanebo, Ltd. 帯状織物構造体およびその製法
EP1937642B1 (en) * 2005-10-19 2014-09-10 Teva Pharmaceutical Industries Ltd Crystals of laquinimod sodium, and process for the manufacture thereof
US20090105272A1 (en) * 2005-12-24 2009-04-23 Grootenhuis Peter D J Prodrugs of modulators of ABC transporters
AU2006332726B2 (en) * 2005-12-28 2012-12-13 Vertex Pharmaceuticals Incorporated. Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
BRPI0713694A2 (pt) * 2006-06-12 2012-10-30 Teva Pharma composição farmacêutica, processo para preparar composição farmacêutica, embalagens vedada, métodos para tratar um indivìduo afligido com uma forma de esclerose múltipla, e para aliviar um sintoma de esclerose múltipla em um indivìduo afligido com uma forma de esclerose múltipla, e, uso da composição farmacêutica
US20080221161A1 (en) * 2007-02-09 2008-09-11 Kalypsys, Inc. Heterocyclic modulators of tgr5 for treatment of disease
EP2977049A1 (en) 2007-12-20 2016-01-27 Teva Pharmaceutical Industries, Ltd. Stable laquinimod preparations
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
AU2009288108B2 (en) * 2008-09-03 2013-10-17 Teva Pharmaceutical Industries, Ltd. 2-oxo-1,2-dihydro-quinoline modulators of immune function
AU2010226400B2 (en) 2009-03-20 2016-07-14 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
RS54707B1 (sr) * 2009-07-30 2016-08-31 Teva Pharmaceutical Industries Ltd. Tretman kronove bolesti lakvinimodom
PL3064206T3 (pl) * 2009-08-10 2020-02-28 Active Biotech Ab Leczenie choroby Huntingtona z zastosowaniem lakwinimodu
NZ602510A (en) * 2010-03-03 2014-11-28 Teva Pharma Treatment of lupus nephritis using laquinimod
SG183513A1 (en) * 2010-03-03 2012-09-27 Teva Pharma Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
NZ602512A (en) * 2010-03-03 2014-07-25 Teva Pharma Treatment of lupus arthritis using laquinimod
CN102267984B (zh) * 2010-06-04 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 4-羟基喹啉-3-酰胺衍生物及其制备方法和用途
RU2013120556A (ru) 2010-10-14 2014-11-20 Иммунар Аб 1,2-гидрокси-2-оксо-хинолин-3-карбоксанилиды в качестве активаторов ahr
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2537517A1 (en) * 2011-06-22 2012-12-26 Active Biotech AB Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
SG11201401330YA (en) 2011-10-12 2014-05-29 Teva Pharma Treatment of multiple sclerosis with combination of laquinimod and fingolimod
CN106063787A (zh) 2012-02-03 2016-11-02 泰华制药工业有限公司 拉喹莫德用于治疗一线抗TNFα疗法失败的克罗恩氏病患者的用途
CA2865519C (en) 2012-02-27 2018-01-02 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl0-5-hydroxyphenyl-1]-1,4-dihydro-4-oxoquinolone-3-carboxamide for treating cystic fibrosis
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
HK1212936A1 (zh) 2012-11-07 2016-06-24 Teva Pharmaceutical Industries Ltd. 拉喹莫德胺盐
US9139529B2 (en) * 2013-01-31 2015-09-22 Vertex Pharmaceuticals Incorporated Substituted quinoxalines as sodium channel modulators
NZ630427A (en) 2013-03-14 2017-06-30 Teva Pharma Crystals of laquinimod sodium and improved process for the manufacture thereof
UY36099A (es) 2014-04-29 2016-02-29 Teva Pharma Laquinimod para el tratamiento de pacientes con esclerosis múltiple remitente recurrente (rrms) con un alto grado de discapacidad
CN107250113B (zh) 2014-10-07 2019-03-29 弗特克斯药品有限公司 囊性纤维化跨膜传导调节蛋白的调节剂的共晶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL289475A (enExample) * 1962-03-01
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
FR2281761A1 (fr) * 1974-08-13 1976-03-12 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
US4107310A (en) 1978-08-15
NL7701398A (nl) 1977-08-15
AU508345B2 (en) 1980-03-20
IE44879L (en) 1977-08-11
DK56077A (da) 1977-08-12
JPS623152B2 (enExample) 1987-01-23
JPS52116479A (en) 1977-09-29
CA1089464A (fr) 1980-11-11
SE441528B (sv) 1985-10-14
ZA77787B (en) 1978-03-29
BE851306A (fr) 1977-08-10
LU76742A1 (enExample) 1977-08-19
AU2221877A (en) 1978-08-17
FR2340735A1 (fr) 1977-09-09
CH620437A5 (enExample) 1980-11-28
GB1572482A (en) 1980-07-30
SU867299A3 (ru) 1981-09-23
DD129552A5 (de) 1978-01-25
SE7700804L (sv) 1977-08-12
DE2705446C2 (enExample) 1989-10-12
DE2705446A1 (de) 1977-08-18
ES455804A1 (es) 1978-01-16
IL51413A0 (en) 1977-04-29
IL51413A (en) 1980-09-16
DK150512B (da) 1987-03-16
IE44879B1 (en) 1982-05-05
DK150512C (da) 1987-11-16

Similar Documents

Publication Publication Date Title
FR2340735B1 (enExample)
DE2760266A1 (enExample)
DE2606550B (enExample)
DK139523C (enExample)
DK142088C (enExample)
DK141392C (enExample)
FI52157B (enExample)
DK141756C (enExample)
JPS5329689B2 (enExample)
JPS5349020U (enExample)
JPS5431750Y2 (enExample)
JPS52126862U (enExample)
JPS5373930U (enExample)
JPS52162741U (enExample)
DK138196C (enExample)
JPS5523838Y2 (enExample)
JPS5322648Y2 (enExample)
JPS5374255U (enExample)
FI760140A7 (enExample)
FI760900A7 (enExample)
DK515376A (enExample)
JPS52108150U (enExample)
JPS52108776U (enExample)
JPS5371330U (enExample)
JPS52159537U (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse